ID   NPC1_HUMAN              Reviewed;        1278 AA.
AC   O15118; B4DET3; Q9P130;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2005, sequence version 2.
DT   10-MAY-2017, entry version 169.
DE   RecName: Full=Niemann-Pick C1 protein;
DE   Flags: Precursor;
GN   Name=NPC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT ILE-642, AND VARIANTS
RP   NPC1.
RX   PubMed=9211849; DOI=10.1126/science.277.5323.228;
RA   Carstea E.D., Morris J.A., Coleman K.G., Loftus S.K., Zhang D.,
RA   Cummings C., Gu J., Rosenfeld M.A., Pavan W.J., Krizman D.B.,
RA   Nagle J., Polymeropoulos M.H., Sturley S.L., Ioannou Y.A.,
RA   Higgins M.E., Comly M., Cooney A., Brown A., Kaneski C.R.,
RA   Blanchette-Mackie E.J., Dwyer N.K., Neufeld E.B., Chang T.-Y.,
RA   Liscum L., Strauss J.F. III, Ohno K., Zeigler M., Carmi R., Sokol J.,
RA   Markie D., O'Neill R.R., van Diggelen O.P., Elleder M.,
RA   Patterson M.C., Brady R.O., Vanier M.T., Pentchev P.G., Tagle D.A.;
RT   "Niemann-Pick C1 disease gene: homology to mediators of cholesterol
RT   homeostasis.";
RL   Science 277:228-231(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS.
RX   PubMed=10425213; DOI=10.1006/bbrc.1999.1070;
RA   Morris J.A., Zhang D., Coleman K.G., Nagle J., Pentchev P.G.,
RA   Carstea E.D.;
RT   "The genomic organization and polymorphism analysis of the human
RT   Niemann-Pick C1 gene.";
RL   Biochem. Biophys. Res. Commun. 261:493-498(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS NPC1 ARG-512; TRP-670;
RP   CYS-825; ILE-849; VAL-874; TYR-948; LEU-954; LEU-958; ALA-1007 AND
RP   THR-1061, AND VARIANTS ARG-215; ILE-642; VAL-858; GLY-971 AND
RP   VAL-1049.
RX   PubMed=11754101; DOI=10.1002/humu.10016;
RA   Bauer P., Knoblich R., Bauer C., Finckh U., Hufen A., Kropp J.,
RA   Braun S., Kustermann-Kuhn B., Schmidt D., Harzer K., Rolfs A.;
RT   "NPC1: complete genomic sequence, mutation analysis, and
RT   characterization of haplotypes.";
RL   Hum. Mutat. 19:30-38(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D.,
RA   Taylor T.D., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Yang X., Abouelleil A., Allen N.R., Anderson S.,
RA   Bloom T., Bugalter B., Butler J., Cook A., DeCaprio D., Engels R.,
RA   Garber M., Gnirke A., Hafez N., Hall J.L., Norman C.H., Itoh T.,
RA   Jaffe D.B., Kuroki Y., Lehoczky J., Lui A., Macdonald P., Mauceli E.,
RA   Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C., Noguchi H.,
RA   O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K.,
RA   Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R.,
RA   Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   GLY-151 AND ILE-642.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   CHARACTERIZATION, AND MUTAGENESIS OF CYS-63 AND CYS-97.
RX   PubMed=9927649; DOI=10.1073/pnas.96.3.805;
RA   Watari H., Blanchette-Mackie E.J., Dwyer N.K., Glick J.M., Patel S.,
RA   Neufeld E.B., Brady R.O., Pentchev P.G., Strauss J.F. III;
RT   "Niemann-Pick C1 protein: obligatory roles for N-terminal domains and
RT   lysosomal targeting in cholesterol mobilization.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:805-810(1999).
RN   [8]
RP   TOPOLOGY, AND GLYCOSYLATION.
RX   PubMed=10821832; DOI=10.1074/jbc.M002184200;
RA   Davies J.P., Ioannou Y.A.;
RT   "Topological analysis of Niemann-Pick C1 protein reveals that the
RT   membrane orientation of the putative sterol-sensing domain is
RT   identical to those of 3-hydroxy-3-methylglutaryl-CoA reductase and
RT   sterol regulatory element binding protein cleavage-activating
RT   protein.";
RL   J. Biol. Chem. 275:24367-24374(2000).
RN   [9]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Placenta;
RX   PubMed=17897319; DOI=10.1111/j.1600-0854.2007.00643.x;
RA   Schroeder B., Wrocklage C., Pan C., Jaeger R., Koesters B.,
RA   Schaefer H., Elsaesser H.-P., Mann M., Hasilik A.;
RT   "Integral and associated lysosomal membrane proteins.";
RL   Traffic 8:1676-1686(2007).
RN   [10]
RP   FUNCTION.
RX   PubMed=18772377; DOI=10.1073/pnas.0807328105;
RA   Infante R.E., Wang M.L., Radhakrishnan A., Kwon H.J., Brown M.S.,
RA   Goldstein J.L.;
RT   "NPC2 facilitates bidirectional transfer of cholesterol between NPC1
RT   and lipid bilayers, a step in cholesterol egress from lysosomes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:15287-15292(2008).
RN   [11]
RP   INTERACTION WITH TMEM97.
RX   PubMed=19583955; DOI=10.1016/j.cmet.2009.05.009;
RA   Bartz F., Kern L., Erz D., Zhu M., Gilbert D., Meinhof T., Wirkner U.,
RA   Erfle H., Muckenthaler M., Pepperkok R., Runz H.;
RT   "Identification of cholesterol-regulating genes by targeted RNAi
RT   screening.";
RL   Cell Metab. 10:63-75(2009).
RN   [12]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-135 AND ASN-524.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [13]
RP   REVIEW ON FUNCTION.
RX   PubMed=18832164; DOI=10.1073/pnas.0808256105;
RA   Subramanian K., Balch W.E.;
RT   "NPC1/NPC2 function as a tag team duo to mobilize cholesterol.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:15223-15224(2008).
RN   [14]
RP   REVIEW ON FUNCTION.
RX   PubMed=20674853; DOI=10.1016/j.cmet.2010.07.004;
RA   Vance J.E.;
RT   "Transfer of cholesterol by the NPC team.";
RL   Cell Metab. 12:105-106(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   REVIEW ON FUNCTION.
RX   PubMed=21412152; DOI=10.1097/MOL.0b013e3283453e69;
RA   Vance J.E., Peake K.B.;
RT   "Function of the Niemann-Pick type C proteins and their bypass by
RT   cyclodextrin.";
RL   Curr. Opin. Lipidol. 22:204-209(2011).
RN   [17]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH EBOLAVIRUS
RP   GLYCOPROTEIN.
RX   PubMed=21866103; DOI=10.1038/nature10348;
RA   Carette J.E., Raaben M., Wong A.C., Herbert A.S., Obernosterer G.,
RA   Mulherkar N., Kuehne A.I., Kranzusch P.J., Griffin A.M., Ruthel G.,
RA   Dal Cin P., Dye J.M., Whelan S.P., Chandran K., Brummelkamp T.R.;
RT   "Ebola virus entry requires the cholesterol transporter Niemann-Pick
RT   C1.";
RL   Nature 477:340-343(2011).
RN   [18]
RP   INTERACTION WITH TIM1, AND FUNCTION (MICROBIAL INFECTION).
RX   PubMed=25855742; DOI=10.1128/JVI.03156-14;
RA   Kuroda M., Fujikura D., Nanbo A., Marzi A., Noyori O., Kajihara M.,
RA   Maruyama J., Matsuno K., Miyamoto H., Yoshida R., Feldmann H.,
RA   Takada A.;
RT   "Interaction between TIM-1 and NPC1 Is Important for Cellular Entry of
RT   Ebola Virus.";
RL   J. Virol. 89:6481-6493(2015).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) OF 23-252 OF MUTANT GLN-70;
RP   GLN-122 AND GLN-185 IN COMPLEX WITH CHOLESTEROL, FUNCTION, DISULFIDE
RP   BONDS, GLYCOSYLATION AT ASN-158 AND ASN-222, AND MUTAGENESIS OF
RP   26-VAL-TRP-27; 39-ARG--ASN-41; ASN-41; ASN-70; 82-THR-LEU-83;
RP   101-PHE-TYR-102; 106-ASN--PHE-108; 110-GLU--THR-112; ASN-122;
RP   144-LEU-GLN-145; 146-TYR-TYR-147; 175-LEU-LEU-176; 180-ASP--ASP-182;
RP   ASN-185; 187-TYR-ASN-188; 191-GLU-TYR-192; 195-ASN-LYS-196;
RP   197-ASP-ASN-198; 199-GLY-GLN-200; 202-PRO-PHE-203; 204-THR-ILE-205 AND
RP   GLY-660.
RX   PubMed=19563754; DOI=10.1016/j.cell.2009.03.049;
RA   Kwon H.J., Abi-Mosleh L., Wang M.L., Deisenhofer J., Goldstein J.L.,
RA   Brown M.S., Infante R.E.;
RT   "Structure of N-terminal domain of NPC1 reveals distinct subdomains
RT   for binding and transfer of cholesterol.";
RL   Cell 137:1213-1224(2009).
RN   [21]
RP   VARIANT NPC1 TRP-992.
RX   PubMed=9634529; DOI=10.1086/301931;
RA   Greer W.L., Riddell D.C., Gillan T.L., Girouard G.S., Sparrow S.M.,
RA   Byers D.M., Dobson M.J., Neumann P.E.;
RT   "The Nova Scotia (type D) form of Niemann-Pick disease is caused by a
RT   G3097-->T transversion in NPC1.";
RL   Am. J. Hum. Genet. 63:52-54(1998).
RN   [22]
RP   VARIANTS NPC1 GLN-934; LEU-940; ASN-948; LEU-954; TRP-992; ALA-1007;
RP   THR-1061 AND VAL-1213.
RX   PubMed=10521290; DOI=10.1086/302620;
RA   Greer W.L., Dobson M.J., Girouard G.S., Byers D.M., Riddell D.C.,
RA   Neumann P.E.;
RT   "Mutations in NPC1 highlight a conserved NPC1-specific cysteine-rich
RT   domain.";
RL   Am. J. Hum. Genet. 65:1252-1260(1999).
RN   [23]
RP   VARIANT NPC1 THR-1061.
RX   PubMed=10521297; DOI=10.1086/302626;
RA   Millat G., Marcais C., Rafi M.A., Yamamoto T., Morris J.A.,
RA   Pentchev P.G., Ohno K., Wenger D.A., Vanier M.T.;
RT   "Niemann-Pick C1 disease: the I1061T substitution is a frequent mutant
RT   allele in patients of Western European descent and correlates with a
RT   classic juvenile phenotype.";
RL   Am. J. Hum. Genet. 65:1321-1329(1999).
RN   [24]
RP   VARIANTS NPC1, AND VARIANTS ARG-215; VAL-858 AND GLN-1266.
RX   PubMed=10480349; DOI=10.1007/s004399900059;
RA   Yamamoto T., Nanba E., Ninomiya H., Higaki K., Taniguchi M., Zhang H.,
RA   Akaboshi S., Watanabe Y., Takeshima T., Inui K., Okada S., Tanaka A.,
RA   Sakuragawa N., Millat G., Vanier M.T., Morris J.A., Pentchev P.G.,
RA   Ohno K.;
RT   "NPC1 gene mutations in Japanese patients with Niemann-Pick disease
RT   type C.";
RL   Hum. Genet. 105:10-16(1999).
RN   [25]
RP   VARIANTS NPC1 GLY-177; SER-237; PRO-473; PRO-510; GLN-518; SER-703;
RP   MET-889; LEU-954; TYR-956; ARG-996; THR-1061; CYS-1088; ARG-1205;
RP   PHE-1213 AND GLU-1236, AND VARIANT ALA-873.
RX   PubMed=11182931; DOI=10.1136/jmg.37.9.707;
RA   Yamamoto T., Ninomiya H., Matsumoto M., Ohta Y., Nanba E.,
RA   Tsutsumi Y., Yamakawa K., Millat G., Vanier M.T., Pentchev P.G.,
RA   Ohno K.;
RT   "Genotype-phenotype relationship of Niemann-Pick disease type C: a
RT   possible correlation between clinical onset and levels of NPC1 protein
RT   in isolated skin fibroblasts.";
RL   J. Med. Genet. 37:707-712(2000).
RN   [26]
RP   VARIANTS NPC1 ARG-92; MET-137; SER-237; ASN-242; VAL-248; THR-401;
RP   GLN-404; ASP-612; TRP-652; CYS-789; CYS-825; VAL-874; SER-888;
RP   PRO-929; LEU-940; ASN-944; ASN-948; GLN-958; ARG-976; CYS-978;
RP   LEU-1004; ALA-1007; GLY-1023; THR-1061; LYS-1089; THR-1142; LYS-1150;
RP   SER-1156; MET-1165; HIS-1186 AND GLY-1189.
RX   PubMed=11349231; DOI=10.1086/320599;
RA   Sun X., Marks D.L., Park W.D., Wheatley C.L., Puri V., O'Brien J.F.,
RA   Kraft D.L., Lundquist P.A., Patterson M.C., Pagano R.E., Snow K.;
RT   "Niemann-Pick C variant detection by altered sphingolipid trafficking
RT   and correlation with mutations within a specific domain of NPC1.";
RL   Am. J. Hum. Genet. 68:1361-1372(2001).
RN   [27]
RP   VARIANTS NPC1 SER-237; HIS-242; ARG-272; ALA-378; GLN-404; GLN-518;
RP   VAL-605; ARG-631; PRO-724; PRO-775; CYS-825; VAL-874; GLN-934;
RP   MET-943; ASN-944; MET-950; SER-986; ARG-992; ALA-1007; THR-1054;
RP   THR-1061; THR-1142; TYR-1168 AND HIS-1186.
RX   PubMed=11333381; DOI=10.1086/320606;
RA   Millat G., Marcais C., Tomasetto C., Chikh K., Fensom A.H., Harzer K.,
RA   Wenger D.A., Ohno K., Vanier M.T.;
RT   "Niemann-Pick C1 disease: correlations between NPC1 mutations, levels
RT   of NPC1 protein, and phenotypes emphasize the functional significance
RT   of the putative sterol-sensing domain and of the cysteine-rich luminal
RT   loop.";
RL   Am. J. Hum. Genet. 68:1373-1385(2001).
RN   [28]
RP   VARIANTS NPC1 ARG-63; GLN-404; VAL-927; TRP-992; ASP-1012 AND
RP   SER-1156.
RX   PubMed=11545687; DOI=10.1097/00125817-200109000-00003;
RA   Meiner V., Shpitzen S., Mandel H., Klar A., Ben-Neriah Z.,
RA   Zlotogora J., Sagi M., Lossos A., Bargal R., Sury V., Carmi R.,
RA   Leitersdorf E., Zeigler M.;
RT   "Clinical-biochemical correlation in molecularly characterized
RT   patients with Niemann-Pick type C.";
RL   Genet. Med. 3:343-348(2001).
RN   [29]
RP   VARIANTS NPC1 ARG-92; TYR-177; TRP-518; CYS-942; CYS-978; ALA-1007
RP   VAL-1035 AND THR-1061, AND VARIANTS ARG-215; ILE-642 AND VAL-858.
RX   PubMed=11479732; DOI=10.1007/s004390100531;
RA   Ribeiro I., Marcao A., Amaral O., Sa Miranda M.C., Vanier M.T.,
RA   Millat G.;
RT   "Niemann-Pick type C disease: NPC1 mutations associated with severe
RT   and mild cellular cholesterol trafficking alterations.";
RL   Hum. Genet. 109:24-32(2001).
RN   [30]
RP   VARIANTS NPC1 GLY-231; SER-237; VAL-874 ASN-948 AND THR-1094, AND
RP   VARIANTS CYS-381 AND ILE-642.
RX   PubMed=12408188; DOI=10.1023/A:1020151801060;
RA   Kaminski W.E., Kluenemann H.H., Ibach B., Aslanidis C., Klein H.E.,
RA   Schmitz G.;
RT   "Identification of novel mutations in the NPC1 gene in German patients
RT   with Niemann-Pick C disease.";
RL   J. Inherit. Metab. Dis. 25:385-389(2002).
RN   [31]
RP   VARIANTS NPC1 LYS-451; LEU-474; CYS-890; ASP-899; SER-910; TRP-992;
RP   ALA-1007; THR-1061 AND SER-1156, AND VARIANTS ARG-215; ILE-642 AND
RP   VAL-858.
RX   PubMed=12401890; DOI=10.1194/jlr.M200203-JLR200;
RA   Tarugi P., Ballarini G., Bembi B., Battisti C., Palmeri S.,
RA   Panzani F., Di Leo E., Martini C., Federico A., Calandra S.;
RT   "Niemann-Pick type C disease: mutations of NPC1 gene and evidence of
RT   abnormal expression of some mutant alleles in fibroblasts.";
RL   J. Lipid Res. 43:1908-1919(2002).
RN   [32]
RP   VARIANT NPC1 ARG-113, VARIANT SER-273, CHARACTERIZATION OF VARIANT
RP   NPC1 ARG-113, AND CHARACTERIZATION OF VARIANT SER-273.
RX   PubMed=12554680; DOI=10.1093/hmg/ddg025;
RA   Blom T.S., Linder M.D., Snow K., Pihko H., Hess M.W., Jokitalo E.,
RA   Veckman V., Syvaenen A.-C., Ikonen E.;
RT   "Defective endocytic trafficking of NPC1 and NPC2 underlying infantile
RT   Niemann-Pick type C disease.";
RL   Hum. Mol. Genet. 12:257-272(2003).
RN   [33]
RP   VARIANTS NPC1 TYR-74; SER-166; SER-222; TYR-247; PHE-380; PRO-388;
RP   CYS-389; TRP-404; LEU-433; SER-509; SER-521; LEU-543; CYS-615;
RP   ARG-640; SER-660; MET-664; VAL-673; PHE-684; LEU-691; VAL-695;
RP   ASN-700; ILE-734; LYS-742; GLU-745; VAL-767; GLY-789; ASN-945;
RP   ARG-1016; GLN-1059; LEU-1087; ILE-1137; VAL-1140; LYS-1205 AND
RP   GLY-1249, AND VARIANTS ARG-215; SER-237; SER-434 AND GLN-1266.
RX   PubMed=12955717; DOI=10.1002/humu.10255;
RA   Park W.D., O'Brien J.F., Lundquist P.A., Kraft D.L., Vockley C.W.,
RA   Karnes P.S., Patterson M.C., Snow K.;
RT   "Identification of 58 novel mutations in Niemann-Pick disease type C:
RT   correlation with biochemical phenotype and importance of PTC1-like
RT   domains in NPC1.";
RL   Hum. Mutat. 22:313-325(2003).
RN   [34]
RP   VARIANTS NPC1 MET-137; TYR-177; TRP-372; LEU-434; LEU-474; TYR-479;
RP   ARG-576; MET-664; PHE-727; LYS-754; PRO-775; LEU-865; THR-926;
RP   CYS-942; ASN-944; HIS-948; GLU-959; 961-ASN--PHE-966 DELINS SER;
RP   ALA-1007; VAL-1035; LYS-1036; THR-1061; ASN-1066; ILE-1156; SER-1156
RP   AND LEU-1224, AND VARIANTS ARG-215; ILE-642; VAL-858 AND GLN-1266.
RX   PubMed=16098014; DOI=10.1111/j.1399-0004.2005.00490.x;
RA   Fernandez-Valero E.M., Ballart A., Iturriaga C., Lluch M., Macias J.,
RA   Vanier M.T., Pineda M., Coll M.J.;
RT   "Identification of 25 new mutations in 40 unrelated Spanish Niemann-
RT   Pick type C patients: genotype-phenotype correlations.";
RL   Clin. Genet. 68:245-254(2005).
RN   [35]
RP   VARIANTS NPC1 SER-968; VAL-1015; ARG-1034 AND LEU-1212, AND VARIANTS
RP   ARG-215; ILE-642; VAL-858 AND GLN-1266.
RX   PubMed=15774455; DOI=10.1136/jnnp.2004.046045;
RA   Yang C.-C., Su Y.-N., Chiou P.-C., Fietz M.J., Yu C.-L., Hwu W.-L.,
RA   Lee M.-J.;
RT   "Six novel NPC1 mutations in Chinese patients with Niemann-Pick
RT   disease type C.";
RL   J. Neurol. Neurosurg. Psych. 76:592-595(2005).
RN   [36]
RP   VARIANTS NPC1 SER-166; TYR-177; PRO-404; LEU-537; LEU-543; LEU-615;
RP   ARG-631; LEU-763; CYS-825; LEU-862; LEU-865; CYS-871; TYR-917;
RP   GLN-934; LEU-940; MET-950; SER-968; ALA-992; ARG-992; TRP-992;
RP   ALA-1007; MET-1036; THR-1061; VAL-1062; ASN-1097; VAL-1174; HIS-1186;
RP   VAL-1216 AND ARG-1240, AND VARIANT MET-511.
RX   PubMed=16126423; DOI=10.1016/j.ymgme.2005.07.007;
RA   Millat G., Baielo N., Molinero S., Rodriguez C., Chikh K.,
RA   Vanier M.T.;
RT   "Niemann-Pick C disease: use of denaturing high performance liquid
RT   chromatography for the detection of NPC1 and NPC2 genetic variations
RT   and impact on management of patients and families.";
RL   Mol. Genet. Metab. 86:220-232(2005).
RN   [37]
RP   VARIANTS NPC1 ASN-666 AND SER-961.
RX   PubMed=16802107; DOI=10.1007/s10545-006-0330-z;
RA   Dvorakova L., Sikora J., Hrebicek M., Hulkova H., Bouckova M.,
RA   Stolnaja L., Elleder M.;
RT   "Subclinical course of adult visceral Niemann-Pick type C1 disease. A
RT   rare or underdiagnosed disorder?";
RL   J. Inherit. Metab. Dis. 29:591-591(2006).
RN   [38]
RP   VARIANT NCP1 MET-137.
RX   PubMed=23453666; DOI=10.1016/j.ajhg.2013.02.004;
RA   Akizu N., Shembesh N.M., Ben-Omran T., Bastaki L., Al-Tawari A.,
RA   Zaki M.S., Koul R., Spencer E., Rosti R.O., Scott E., Nickerson E.,
RA   Gabriel S., da Gente G., Li J., Deardorff M.A., Conlin L.K.,
RA   Horton M.A., Zackai E.H., Sherr E.H., Gleeson J.G.;
RT   "Whole-exome sequencing identifies mutated c12orf57 in recessive
RT   corpus callosum hypoplasia.";
RL   Am. J. Hum. Genet. 92:392-400(2013).
CC   -!- FUNCTION: Intracellular cholesterol transporter which acts in
CC       concert with NPC2 and plays an important role in the egress of
CC       cholesterol from the endosomal/lysosomal compartment. Both NPC1
CC       and NPC2 function as the cellular 'tag team duo' (TTD) to catalyze
CC       the mobilization of cholesterol within the multivesicular
CC       environment of the late endosome (LE) to effect egress through the
CC       limiting bilayer of the LE. NPC2 binds unesterified cholesterol
CC       that has been released from LDLs in the lumen of the late
CC       endosomes/lysosomes and transfers it to the cholesterol-binding
CC       pocket of the N-terminal domain of NPC1. Cholesterol binds to NPC1
CC       with the hydroxyl group buried in the binding pocket and is
CC       exported from the limiting membrane of late endosomes/ lysosomes
CC       to the ER and plasma membrane by an unknown mechanism. Binds
CC       oxysterol with higher affinity than cholesterol. May play a role
CC       in vesicular trafficking in glia, a process that may be crucial
CC       for maintaining the structural and functional integrity of nerve
CC       terminals. {ECO:0000269|PubMed:18772377,
CC       ECO:0000269|PubMed:19563754}.
CC   -!- FUNCTION: (Microbial infection) Acts as an endosomal entry
CC       receptor for ebolavirus. {ECO:0000269|PubMed:21866103,
CC       ECO:0000269|PubMed:25855742}.
CC   -!- SUBUNIT: Interacts with TMEM97. Interacts (via the second lumenal
CC       domain) with NPC2 in a cholestrol-dependent manner (By
CC       similarity). Interacts with TIM1 (PubMed:25855742). {ECO:0000250,
CC       ECO:0000269|PubMed:25855742}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with ebolavirus
CC       glycoprotein. {ECO:0000269|PubMed:21866103}.
CC   -!- INTERACTION:
CC       Q03135:CAV1; NbExp=3; IntAct=EBI-2368710, EBI-603614;
CC   -!- SUBCELLULAR LOCATION: Late endosome membrane
CC       {ECO:0000269|PubMed:17897319}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:17897319}. Lysosome membrane
CC       {ECO:0000269|PubMed:17897319}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:17897319}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O15118-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O15118-2; Sequence=VSP_056431, VSP_056432, VSP_056433;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: A cysteine-rich N-terminal domain and a C-terminal domain
CC       containing a di-leucine motif necessary for lysosomal targeting
CC       are critical for mobilization of cholesterol from lysosomes.
CC   -!- PTM: Glycosylated. {ECO:0000269|PubMed:10821832,
CC       ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:19563754}.
CC   -!- DISEASE: Niemann-Pick disease C1 (NPC1) [MIM:257220]: A lysosomal
CC       storage disorder that affects the viscera and the central nervous
CC       system. It is due to defective intracellular processing and
CC       transport of low-density lipoprotein derived cholesterol. It
CC       causes accumulation of cholesterol in lysosomes, with delayed
CC       induction of cholesterol homeostatic reactions. Niemann-Pick
CC       disease type C1 has a highly variable clinical phenotype. Clinical
CC       features include variable hepatosplenomegaly and severe
CC       progressive neurological dysfunction such as ataxia, dystonia and
CC       dementia. The age of onset can vary from infancy to late
CC       adulthood. An allelic variant of Niemann-Pick disease type C1 is
CC       found in people with Nova Scotia ancestry. Patients with the Nova
CC       Scotian clinical variant are less severely affected.
CC       {ECO:0000269|PubMed:10480349, ECO:0000269|PubMed:10521290,
CC       ECO:0000269|PubMed:10521297, ECO:0000269|PubMed:11182931,
CC       ECO:0000269|PubMed:11333381, ECO:0000269|PubMed:11349231,
CC       ECO:0000269|PubMed:11479732, ECO:0000269|PubMed:11545687,
CC       ECO:0000269|PubMed:11754101, ECO:0000269|PubMed:12401890,
CC       ECO:0000269|PubMed:12408188, ECO:0000269|PubMed:12554680,
CC       ECO:0000269|PubMed:12955717, ECO:0000269|PubMed:15774455,
CC       ECO:0000269|PubMed:16098014, ECO:0000269|PubMed:16126423,
CC       ECO:0000269|PubMed:16802107, ECO:0000269|PubMed:9211849,
CC       ECO:0000269|PubMed:9634529}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the patched family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF002020; AAB63982.1; -; mRNA.
DR   EMBL; AF157379; AAD48006.1; -; Genomic_DNA.
DR   EMBL; AF157365; AAD48006.1; JOINED; Genomic_DNA.
DR   EMBL; AF157366; AAD48006.1; JOINED; Genomic_DNA.
DR   EMBL; AF157367; AAD48006.1; JOINED; Genomic_DNA.
DR   EMBL; AF157368; AAD48006.1; JOINED; Genomic_DNA.
DR   EMBL; AF157369; AAD48006.1; JOINED; Genomic_DNA.
DR   EMBL; AF157370; AAD48006.1; JOINED; Genomic_DNA.
DR   EMBL; AF157371; AAD48006.1; JOINED; Genomic_DNA.
DR   EMBL; AF157372; AAD48006.1; JOINED; Genomic_DNA.
DR   EMBL; AF157373; AAD48006.1; JOINED; Genomic_DNA.
DR   EMBL; AF157374; AAD48006.1; JOINED; Genomic_DNA.
DR   EMBL; AF157375; AAD48006.1; JOINED; Genomic_DNA.
DR   EMBL; AF157376; AAD48006.1; JOINED; Genomic_DNA.
DR   EMBL; AF157377; AAD48006.1; JOINED; Genomic_DNA.
DR   EMBL; AF157378; AAD48006.1; JOINED; Genomic_DNA.
DR   EMBL; AF338230; AAK25791.1; -; Genomic_DNA.
DR   EMBL; AH009108; AAF28875.1; -; Genomic_DNA.
DR   EMBL; AK293779; BAG57194.1; -; mRNA.
DR   EMBL; AC010853; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC026634; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC063302; AAH63302.1; -; mRNA.
DR   CCDS; CCDS11878.1; -. [O15118-1]
DR   RefSeq; NP_000262.2; NM_000271.4. [O15118-1]
DR   UniGene; Hs.464779; -.
DR   UniGene; Hs.715623; -.
DR   PDB; 3GKH; X-ray; 1.81 A; A=23-252.
DR   PDB; 3GKI; X-ray; 1.80 A; A=23-252.
DR   PDB; 3GKJ; X-ray; 1.60 A; A=23-252.
DR   PDB; 3JD8; EM; 4.43 A; A=1-1267.
DR   PDB; 5F18; X-ray; 2.00 A; A=374-620.
DR   PDB; 5F1B; X-ray; 2.30 A; C=374-620.
DR   PDB; 5HNS; X-ray; 2.45 A; A/B=387-618.
DR   PDB; 5I31; X-ray; 3.35 A; A=341-1246.
DR   PDB; 5JNX; EM; 6.56 A; A=1-1278.
DR   PDB; 5KWY; X-ray; 2.40 A; A/B=374-620.
DR   PDBsum; 3GKH; -.
DR   PDBsum; 3GKI; -.
DR   PDBsum; 3GKJ; -.
DR   PDBsum; 3JD8; -.
DR   PDBsum; 5F18; -.
DR   PDBsum; 5F1B; -.
DR   PDBsum; 5HNS; -.
DR   PDBsum; 5I31; -.
DR   PDBsum; 5JNX; -.
DR   PDBsum; 5KWY; -.
DR   ProteinModelPortal; O15118; -.
DR   SMR; O15118; -.
DR   BioGrid; 110925; 13.
DR   DIP; DIP-53217N; -.
DR   IntAct; O15118; 5.
DR   STRING; 9606.ENSP00000269228; -.
DR   BindingDB; O15118; -.
DR   ChEMBL; CHEMBL1293277; -.
DR   SwissLipids; SLP:000000478; -.
DR   TCDB; 2.A.6.6.1; the resistance-nodulation-cell division (rnd) superfamily.
DR   iPTMnet; O15118; -.
DR   PhosphoSitePlus; O15118; -.
DR   SwissPalm; O15118; -.
DR   BioMuta; NPC1; -.
DR   EPD; O15118; -.
DR   MaxQB; O15118; -.
DR   PaxDb; O15118; -.
DR   PeptideAtlas; O15118; -.
DR   PRIDE; O15118; -.
DR   Ensembl; ENST00000269228; ENSP00000269228; ENSG00000141458. [O15118-1]
DR   GeneID; 4864; -.
DR   KEGG; hsa:4864; -.
DR   UCSC; uc002kum.5; human. [O15118-1]
DR   CTD; 4864; -.
DR   DisGeNET; 4864; -.
DR   GeneCards; NPC1; -.
DR   GeneReviews; NPC1; -.
DR   H-InvDB; HIX0039703; -.
DR   HGNC; HGNC:7897; NPC1.
DR   HPA; CAB070132; -.
DR   HPA; HPA026618; -.
DR   MalaCards; NPC1; -.
DR   MIM; 257220; phenotype.
DR   MIM; 607623; gene.
DR   neXtProt; NX_O15118; -.
DR   OpenTargets; ENSG00000141458; -.
DR   Orphanet; 216986; Niemann-Pick disease type C, adult neurologic onset.
DR   Orphanet; 216981; Niemann-Pick disease type C, juvenile neurologic onset.
DR   Orphanet; 216978; Niemann-Pick disease type C, late infantile neurologic onset.
DR   Orphanet; 216975; Niemann-Pick disease type C, severe early infantile neurologic onset.
DR   Orphanet; 216972; Niemann-Pick disease type C, severe perinatal form.
DR   PharmGKB; PA31698; -.
DR   eggNOG; KOG1933; Eukaryota.
DR   eggNOG; ENOG410XR54; LUCA.
DR   GeneTree; ENSGT00800000124043; -.
DR   HOGENOM; HOG000036674; -.
DR   HOVERGEN; HBG003913; -.
DR   InParanoid; O15118; -.
DR   KO; K12385; -.
DR   OMA; ITRAFTM; -.
DR   OrthoDB; EOG091G00JD; -.
DR   PhylomeDB; O15118; -.
DR   TreeFam; TF300416; -.
DR   Reactome; R-HSA-171052; LDL-mediated lipid transport.
DR   ChiTaRS; NPC1; human.
DR   EvolutionaryTrace; O15118; -.
DR   GeneWiki; NPC1; -.
DR   GenomeRNAi; 4864; -.
DR   PRO; PR:O15118; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000141458; -.
DR   CleanEx; HS_NPC1; -.
DR   ExpressionAtlas; O15118; baseline and differential.
DR   Genevisible; O15118; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; ISS:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0031902; C:late endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0005764; C:lysosome; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0005635; C:nuclear envelope; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0015485; F:cholesterol binding; IDA:UniProtKB.
DR   GO; GO:0004872; F:receptor activity; TAS:ProtInc.
DR   GO; GO:0015248; F:sterol transporter activity; TAS:ProtInc.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc.
DR   GO; GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0007628; P:adult walking behavior; IEA:Ensembl.
DR   GO; GO:0006914; P:autophagy; IGI:MGI.
DR   GO; GO:0008206; P:bile acid metabolic process; ISS:UniProtKB.
DR   GO; GO:0071404; P:cellular response to low-density lipoprotein particle stimulus; IEA:Ensembl.
DR   GO; GO:0071383; P:cellular response to steroid hormone stimulus; IEA:Ensembl.
DR   GO; GO:0033344; P:cholesterol efflux; IDA:BHF-UCL.
DR   GO; GO:0042632; P:cholesterol homeostasis; IDA:UniProtKB.
DR   GO; GO:0008203; P:cholesterol metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0030301; P:cholesterol transport; IDA:UniProtKB.
DR   GO; GO:0090150; P:establishment of protein localization to membrane; IDA:UniProtKB.
DR   GO; GO:0007041; P:lysosomal transport; ISS:UniProtKB.
DR   GO; GO:0031579; P:membrane raft organization; IMP:UniProtKB.
DR   GO; GO:0060548; P:negative regulation of cell death; IEA:Ensembl.
DR   GO; GO:0016242; P:negative regulation of macroautophagy; IEA:Ensembl.
DR   GO; GO:2000189; P:positive regulation of cholesterol homeostasis; IMP:CACAO.
DR   GO; GO:0006486; P:protein glycosylation; IDA:UniProtKB.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; TAS:Reactome.
DR   GO; GO:0046686; P:response to cadmium ion; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0046718; P:viral entry into host cell; IMP:CACAO.
DR   InterPro; IPR004765; NP_C_type.
DR   InterPro; IPR032190; NPC1_N.
DR   InterPro; IPR003392; Ptc/Disp.
DR   InterPro; IPR000731; SSD.
DR   PANTHER; PTHR10796:SF176; PTHR10796:SF176; 1.
DR   Pfam; PF16414; NPC1_N; 1.
DR   Pfam; PF02460; Patched; 1.
DR   Pfam; PF12349; Sterol-sensing; 1.
DR   TIGRFAMs; TIGR00917; 2A060601; 1.
DR   PROSITE; PS50156; SSD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cholesterol metabolism;
KW   Complete proteome; Disease mutation; Disulfide bond; Endosome;
KW   Glycoprotein; Host cell receptor for virus entry;
KW   Host-virus interaction; Lipid metabolism; Lysosome; Membrane;
KW   Niemann-Pick disease; Polymorphism; Receptor; Reference proteome;
KW   Signal; Steroid metabolism; Sterol metabolism; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23   1278       Niemann-Pick C1 protein.
FT                                /FTId=PRO_0000023261.
FT   TOPO_DOM     23    269       Lumenal. {ECO:0000255}.
FT   TRANSMEM    270    290       Helical. {ECO:0000255}.
FT   TOPO_DOM    291    350       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    351    371       Helical. {ECO:0000255}.
FT   TOPO_DOM    372    620       Lumenal. {ECO:0000255}.
FT   TRANSMEM    621    641       Helical. {ECO:0000255}.
FT   TOPO_DOM    642    654       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    655    675       Helical. {ECO:0000255}.
FT   TOPO_DOM    676    677       Lumenal. {ECO:0000255}.
FT   TRANSMEM    678    698       Helical. {ECO:0000255}.
FT   TOPO_DOM    699    734       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    735    755       Helical. {ECO:0000255}.
FT   TOPO_DOM    756    759       Lumenal. {ECO:0000255}.
FT   TRANSMEM    760    780       Helical. {ECO:0000255}.
FT   TOPO_DOM    781    832       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    833    853       Helical. {ECO:0000255}.
FT   TOPO_DOM    854   1098       Lumenal. {ECO:0000255}.
FT   TRANSMEM   1099   1119       Helical. {ECO:0000255}.
FT   TOPO_DOM   1120   1124       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1125   1145       Helical. {ECO:0000255}.
FT   TOPO_DOM   1146   1146       Lumenal. {ECO:0000255}.
FT   TRANSMEM   1147   1167       Helical. {ECO:0000255}.
FT   TOPO_DOM   1168   1195       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1196   1216       Helical. {ECO:0000255}.
FT   TOPO_DOM   1217   1227       Lumenal. {ECO:0000255}.
FT   TRANSMEM   1228   1248       Helical. {ECO:0000255}.
FT   TOPO_DOM   1249   1278       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      620    785       SSD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00199}.
FT   REGION      175    205       Important for cholesterol binding and
FT                                cholesterol transfer from NPC1 to
FT                                liposomes.
FT   MOTIF      1275   1278       Di-leucine motif.
FT   COMPBIAS    249    259       Poly-Pro.
FT   BINDING      41     41       Cholesterol.
FT                                {ECO:0000269|PubMed:19563754}.
FT   BINDING      79     79       Cholesterol.
FT                                {ECO:0000269|PubMed:19563754}.
FT   SITE        108    108       Important for cholesterol binding.
FT   CARBOHYD     70     70       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000305|PubMed:10821832}.
FT   CARBOHYD    122    122       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000305|PubMed:10821832}.
FT   CARBOHYD    135    135       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    158    158       N-linked (GlcNAc...) asparagine;
FT                                atypical. {ECO:0000269|PubMed:19563754}.
FT   CARBOHYD    185    185       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000305|PubMed:10821832}.
FT   CARBOHYD    222    222       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19563754}.
FT   CARBOHYD    452    452       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    459    459       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    478    478       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    524    524       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    961    961       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    968    968       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1064   1064       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1072   1072       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     25     74       {ECO:0000269|PubMed:19563754}.
FT   DISULFID     31     42       {ECO:0000269|PubMed:19563754}.
FT   DISULFID     63    109       {ECO:0000269|PubMed:19563754}.
FT   DISULFID     75    113       {ECO:0000269|PubMed:19563754}.
FT   DISULFID     97    238       {ECO:0000269|PubMed:19563754}.
FT   DISULFID    100    160       {ECO:0000269|PubMed:19563754}.
FT   DISULFID    177    184       {ECO:0000269|PubMed:19563754}.
FT   DISULFID    227    243       {ECO:0000269|PubMed:19563754}.
FT   DISULFID    240    247       {ECO:0000269|PubMed:19563754}.
FT   VAR_SEQ       1    267       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056431.
FT   VAR_SEQ     318    318       K -> KGTAWLLTSTFPSSPVLP (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056432.
FT   VAR_SEQ     519    586       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056433.
FT   VARIANT      63     63       C -> R (in NPC1; dbSNP:rs747049347).
FT                                {ECO:0000269|PubMed:11545687}.
FT                                /FTId=VAR_043172.
FT   VARIANT      74     74       C -> Y (in NPC1).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043173.
FT   VARIANT      92     92       Q -> R (in NPC1).
FT                                {ECO:0000269|PubMed:11349231,
FT                                ECO:0000269|PubMed:11479732}.
FT                                /FTId=VAR_043174.
FT   VARIANT     113    113       C -> R (in NPC1; partially mislocalized
FT                                from late endocytic organelles diffusely
FT                                to the cell periphery; localizes to the
FT                                endoplasmic reticulum Rab7-negative
FT                                endosomes and the cell surface; does not
FT                                clears the lysosomal cholesterol
FT                                accumulation in NPC1-deficient cells;
FT                                dbSNP:rs120074136).
FT                                {ECO:0000269|PubMed:12554680}.
FT                                /FTId=VAR_043175.
FT   VARIANT     137    137       T -> M (in NPC1; dbSNP:rs372947142).
FT                                {ECO:0000269|PubMed:11349231,
FT                                ECO:0000269|PubMed:16098014,
FT                                ECO:0000269|PubMed:23453666}.
FT                                /FTId=VAR_043176.
FT   VARIANT     151    151       S -> G (in dbSNP:rs17855819).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_043177.
FT   VARIANT     166    166       P -> S (in NPC1; dbSNP:rs866966704).
FT                                {ECO:0000269|PubMed:12955717,
FT                                ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_043178.
FT   VARIANT     177    177       C -> G (in NPC1; late infantile form).
FT                                {ECO:0000269|PubMed:11182931}.
FT                                /FTId=VAR_008815.
FT   VARIANT     177    177       C -> Y (in NPC1; dbSNP:rs80358252).
FT                                {ECO:0000269|PubMed:11479732,
FT                                ECO:0000269|PubMed:16098014,
FT                                ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_015561.
FT   VARIANT     215    215       H -> R (common polymorphism in Japanese;
FT                                dbSNP:rs1805081).
FT                                {ECO:0000269|PubMed:10480349,
FT                                ECO:0000269|PubMed:11479732,
FT                                ECO:0000269|PubMed:11754101,
FT                                ECO:0000269|PubMed:12401890,
FT                                ECO:0000269|PubMed:12955717,
FT                                ECO:0000269|PubMed:15774455,
FT                                ECO:0000269|PubMed:16098014}.
FT                                /FTId=VAR_008816.
FT   VARIANT     222    222       N -> S (in NPC1; dbSNP:rs55680026).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043179.
FT   VARIANT     231    231       V -> G (in NPC1).
FT                                {ECO:0000269|PubMed:12408188}.
FT                                /FTId=VAR_043180.
FT   VARIANT     237    237       P -> S (in NPC1; late infantile form;
FT                                dbSNP:rs80358251).
FT                                {ECO:0000269|PubMed:11182931,
FT                                ECO:0000269|PubMed:11333381,
FT                                ECO:0000269|PubMed:11349231,
FT                                ECO:0000269|PubMed:12408188,
FT                                ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_008817.
FT   VARIANT     242    242       D -> H (in NPC1).
FT                                {ECO:0000269|PubMed:11333381}.
FT                                /FTId=VAR_043181.
FT   VARIANT     242    242       D -> N (in NPC1).
FT                                {ECO:0000269|PubMed:11349231}.
FT                                /FTId=VAR_043182.
FT   VARIANT     247    247       C -> Y (in NPC1).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043183.
FT   VARIANT     248    248       G -> V (in NPC1).
FT                                {ECO:0000269|PubMed:11349231}.
FT                                /FTId=VAR_043184.
FT   VARIANT     272    272       M -> R (in NPC1).
FT                                {ECO:0000269|PubMed:11333381}.
FT                                /FTId=VAR_043185.
FT   VARIANT     273    273       W -> S (colocalizes with the wild-type
FT                                protein with Rab7-positive late
FT                                endosomes; clears the lysosomal
FT                                cholesterol accumulation in NPC1-
FT                                deficient cells).
FT                                {ECO:0000269|PubMed:12554680}.
FT                                /FTId=VAR_043186.
FT   VARIANT     333    333       G -> D.
FT                                /FTId=VAR_008818.
FT   VARIANT     372    372       R -> W (in NPC1).
FT                                {ECO:0000269|PubMed:16098014}.
FT                                /FTId=VAR_043187.
FT   VARIANT     378    378       V -> A (in NPC1; dbSNP:rs120074134).
FT                                {ECO:0000269|PubMed:11333381}.
FT                                /FTId=VAR_015562.
FT   VARIANT     380    380       L -> F (in NPC1).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043188.
FT   VARIANT     381    381       W -> C. {ECO:0000269|PubMed:12408188}.
FT                                /FTId=VAR_043189.
FT   VARIANT     388    388       A -> P (in NPC1).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043190.
FT   VARIANT     389    389       R -> C (in NPC1).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043191.
FT   VARIANT     401    401       P -> T (in NPC1).
FT                                {ECO:0000269|PubMed:11349231}.
FT                                /FTId=VAR_043192.
FT   VARIANT     404    404       R -> P (in NPC1).
FT                                {ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_043193.
FT   VARIANT     404    404       R -> Q (in NPC1; dbSNP:rs139751448).
FT                                {ECO:0000269|PubMed:11333381,
FT                                ECO:0000269|PubMed:11349231,
FT                                ECO:0000269|PubMed:11545687}.
FT                                /FTId=VAR_043194.
FT   VARIANT     404    404       R -> W (in NPC1).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043195.
FT   VARIANT     433    433       P -> L (in NPC1).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043196.
FT   VARIANT     434    434       P -> L (in NPC1; dbSNP:rs774333145).
FT                                {ECO:0000269|PubMed:16098014}.
FT                                /FTId=VAR_043197.
FT   VARIANT     434    434       P -> S (in dbSNP:rs61731962).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043198.
FT   VARIANT     451    451       E -> K (in NPC1; dbSNP:rs781065429).
FT                                {ECO:0000269|PubMed:12401890}.
FT                                /FTId=VAR_043199.
FT   VARIANT     472    472       L -> P.
FT                                /FTId=VAR_008819.
FT   VARIANT     473    473       S -> P (in NPC1; late infantile form).
FT                                {ECO:0000269|PubMed:11182931}.
FT                                /FTId=VAR_008820.
FT   VARIANT     474    474       P -> L (in NPC1; dbSNP:rs372445155).
FT                                {ECO:0000269|PubMed:12401890,
FT                                ECO:0000269|PubMed:16098014}.
FT                                /FTId=VAR_043200.
FT   VARIANT     479    479       C -> Y (in NPC1).
FT                                {ECO:0000269|PubMed:16098014}.
FT                                /FTId=VAR_043201.
FT   VARIANT     509    509       Y -> S (in NPC1).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043202.
FT   VARIANT     510    510       H -> P (in NPC1; late infantile form).
FT                                {ECO:0000269|PubMed:11182931}.
FT                                /FTId=VAR_008821.
FT   VARIANT     511    511       T -> M (in dbSNP:rs13381670).
FT                                {ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_043203.
FT   VARIANT     512    512       H -> R (in NPC1).
FT                                {ECO:0000269|PubMed:11754101}.
FT                                /FTId=VAR_043204.
FT   VARIANT     518    518       R -> Q (in NPC1; late infantile form;
FT                                Common in Japanese; dbSNP:rs483352886).
FT                                {ECO:0000269|PubMed:11182931,
FT                                ECO:0000269|PubMed:11333381}.
FT                                /FTId=VAR_008822.
FT   VARIANT     518    518       R -> W (in NPC1; dbSNP:rs377515417).
FT                                {ECO:0000269|PubMed:11479732}.
FT                                /FTId=VAR_043205.
FT   VARIANT     521    521       A -> S (in NPC1; dbSNP:rs138184115).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043206.
FT   VARIANT     537    537       F -> L (in NPC1).
FT                                {ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_043207.
FT   VARIANT     543    543       P -> L (in NPC1; dbSNP:rs369368181).
FT                                {ECO:0000269|PubMed:12955717,
FT                                ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_043208.
FT   VARIANT     574    574       T -> K (in NPC1).
FT                                /FTId=VAR_043209.
FT   VARIANT     576    576       K -> R (in NPC1; dbSNP:rs761660695).
FT                                {ECO:0000269|PubMed:16098014}.
FT                                /FTId=VAR_043210.
FT   VARIANT     605    605       A -> V (in NPC1).
FT                                {ECO:0000269|PubMed:11333381}.
FT                                /FTId=VAR_043211.
FT   VARIANT     612    612       E -> D (in NPC1).
FT                                {ECO:0000269|PubMed:11349231}.
FT                                /FTId=VAR_043212.
FT   VARIANT     615    615       R -> C (in NPC1; dbSNP:rs745777805).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043213.
FT   VARIANT     615    615       R -> L (in NPC1; dbSNP:rs773351341).
FT                                {ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_043214.
FT   VARIANT     631    631       M -> R (in NPC1).
FT                                {ECO:0000269|PubMed:11333381,
FT                                ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_043215.
FT   VARIANT     640    640       G -> R (in NPC1).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043216.
FT   VARIANT     642    642       M -> I (in dbSNP:rs1788799).
FT                                {ECO:0000269|PubMed:11479732,
FT                                ECO:0000269|PubMed:11754101,
FT                                ECO:0000269|PubMed:12401890,
FT                                ECO:0000269|PubMed:12408188,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:15774455,
FT                                ECO:0000269|PubMed:16098014,
FT                                ECO:0000269|PubMed:9211849}.
FT                                /FTId=VAR_008823.
FT   VARIANT     652    652       S -> W (in NPC1).
FT                                {ECO:0000269|PubMed:11349231}.
FT                                /FTId=VAR_043217.
FT   VARIANT     660    660       G -> S (in NPC1).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043218.
FT   VARIANT     664    664       V -> M (in NPC1; dbSNP:rs376213990).
FT                                {ECO:0000269|PubMed:12955717,
FT                                ECO:0000269|PubMed:16098014}.
FT                                /FTId=VAR_043219.
FT   VARIANT     666    666       S -> N (in NPC1; dbSNP:rs750480579).
FT                                {ECO:0000269|PubMed:16802107}.
FT                                /FTId=VAR_043220.
FT   VARIANT     670    670       C -> W (in NPC1).
FT                                {ECO:0000269|PubMed:11754101}.
FT                                /FTId=VAR_043221.
FT   VARIANT     673    673       G -> V (in NPC1).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043222.
FT   VARIANT     684    684       L -> F (in NPC1).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043223.
FT   VARIANT     691    691       P -> L (in NPC1).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043224.
FT   VARIANT     695    695       L -> V (in NPC1; dbSNP:rs370323921).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043225.
FT   VARIANT     700    700       D -> N (in NPC1).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043226.
FT   VARIANT     703    703       F -> S (in NPC1).
FT                                {ECO:0000269|PubMed:11182931}.
FT                                /FTId=VAR_043227.
FT   VARIANT     724    724       L -> P (in NPC1).
FT                                {ECO:0000269|PubMed:11333381}.
FT                                /FTId=VAR_043228.
FT   VARIANT     727    727       V -> F (in NPC1).
FT                                {ECO:0000269|PubMed:16098014}.
FT                                /FTId=VAR_043229.
FT   VARIANT     734    734       S -> I (in NPC1; dbSNP:rs757475924).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043230.
FT   VARIANT     742    742       E -> K (in NPC1).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043231.
FT   VARIANT     745    745       A -> E (in NPC1; dbSNP:rs752386083).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043232.
FT   VARIANT     754    754       M -> K (in NPC1).
FT                                {ECO:0000269|PubMed:16098014}.
FT                                /FTId=VAR_043233.
FT   VARIANT     757    757       V -> A.
FT                                /FTId=VAR_008824.
FT   VARIANT     763    763       F -> L (in NPC1).
FT                                {ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_043234.
FT   VARIANT     767    767       A -> V (in NPC1).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043235.
FT   VARIANT     775    775       Q -> P (in NPC1; dbSNP:rs80358253).
FT                                {ECO:0000269|PubMed:11333381,
FT                                ECO:0000269|PubMed:16098014}.
FT                                /FTId=VAR_043236.
FT   VARIANT     789    789       R -> C (in NPC1).
FT                                {ECO:0000269|PubMed:11349231}.
FT                                /FTId=VAR_043237.
FT   VARIANT     789    789       R -> G (in NPC1).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043238.
FT   VARIANT     825    825       Y -> C (in NPC1; dbSNP:rs550562774).
FT                                {ECO:0000269|PubMed:11333381,
FT                                ECO:0000269|PubMed:11349231,
FT                                ECO:0000269|PubMed:11754101,
FT                                ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_043239.
FT   VARIANT     849    849       S -> I (in NPC1).
FT                                {ECO:0000269|PubMed:11754101}.
FT                                /FTId=VAR_043240.
FT   VARIANT     858    858       I -> V (common polymorphism in Japanese;
FT                                dbSNP:rs1805082).
FT                                {ECO:0000269|PubMed:10480349,
FT                                ECO:0000269|PubMed:11479732,
FT                                ECO:0000269|PubMed:11754101,
FT                                ECO:0000269|PubMed:12401890,
FT                                ECO:0000269|PubMed:15774455,
FT                                ECO:0000269|PubMed:16098014}.
FT                                /FTId=VAR_008825.
FT   VARIANT     862    862       Q -> L (in NPC1).
FT                                {ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_043241.
FT   VARIANT     865    865       S -> L (in NPC1).
FT                                {ECO:0000269|PubMed:16098014,
FT                                ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_043242.
FT   VARIANT     871    871       Y -> C (in NPC1).
FT                                {ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_043243.
FT   VARIANT     873    873       V -> A. {ECO:0000269|PubMed:11182931}.
FT                                /FTId=VAR_043244.
FT   VARIANT     874    874       D -> V (in NPC1; dbSNP:rs372030650).
FT                                {ECO:0000269|PubMed:11333381,
FT                                ECO:0000269|PubMed:11349231,
FT                                ECO:0000269|PubMed:11754101}.
FT                                /FTId=VAR_043245.
FT   VARIANT     888    888       P -> S (in NPC1).
FT                                {ECO:0000269|PubMed:11349231}.
FT                                /FTId=VAR_043246.
FT   VARIANT     889    889       V -> M (in NPC1; adult form;
FT                                dbSNP:rs120074130).
FT                                {ECO:0000269|PubMed:11182931}.
FT                                /FTId=VAR_008826.
FT   VARIANT     890    890       Y -> C (in NPC1).
FT                                {ECO:0000269|PubMed:12401890}.
FT                                /FTId=VAR_043247.
FT   VARIANT     899    899       Y -> D (in NPC1).
FT                                {ECO:0000269|PubMed:12401890}.
FT                                /FTId=VAR_043248.
FT   VARIANT     910    910       G -> S (in NPC1; dbSNP:rs768999208).
FT                                {ECO:0000269|PubMed:12401890}.
FT                                /FTId=VAR_043249.
FT   VARIANT     917    917       D -> Y (in NPC1).
FT                                {ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_043250.
FT   VARIANT     926    926       A -> T (in NPC1; dbSNP:rs564631426).
FT                                {ECO:0000269|PubMed:16098014}.
FT                                /FTId=VAR_043251.
FT   VARIANT     927    927       A -> V (in NPC1; dbSNP:rs753768576).
FT                                {ECO:0000269|PubMed:11545687}.
FT                                /FTId=VAR_043252.
FT   VARIANT     928    928       Q -> P (in NPC1; dbSNP:rs28940897).
FT                                /FTId=VAR_008827.
FT   VARIANT     929    929       L -> P (in NPC1).
FT                                {ECO:0000269|PubMed:11349231}.
FT                                /FTId=VAR_043253.
FT   VARIANT     934    934       R -> Q (in NPC1; dbSNP:rs786204714).
FT                                {ECO:0000269|PubMed:10521290,
FT                                ECO:0000269|PubMed:11333381,
FT                                ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_008828.
FT   VARIANT     940    940       S -> L (in NPC1; dbSNP:rs143124972).
FT                                {ECO:0000269|PubMed:10521290,
FT                                ECO:0000269|PubMed:11349231,
FT                                ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_008829.
FT   VARIANT     942    942       W -> C (in NPC1).
FT                                {ECO:0000269|PubMed:11479732,
FT                                ECO:0000269|PubMed:16098014}.
FT                                /FTId=VAR_043254.
FT   VARIANT     943    943       I -> M (in NPC1).
FT                                {ECO:0000269|PubMed:11333381}.
FT                                /FTId=VAR_043255.
FT   VARIANT     944    944       D -> N (in NPC1; dbSNP:rs748837410).
FT                                {ECO:0000269|PubMed:11333381,
FT                                ECO:0000269|PubMed:11349231,
FT                                ECO:0000269|PubMed:16098014}.
FT                                /FTId=VAR_043256.
FT   VARIANT     945    945       D -> N (in NPC1).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043257.
FT   VARIANT     948    948       D -> H (in NPC1).
FT                                {ECO:0000269|PubMed:16098014}.
FT                                /FTId=VAR_043258.
FT   VARIANT     948    948       D -> N (in NPC1).
FT                                {ECO:0000269|PubMed:10521290,
FT                                ECO:0000269|PubMed:11349231,
FT                                ECO:0000269|PubMed:12408188}.
FT                                /FTId=VAR_008830.
FT   VARIANT     948    948       D -> Y (in NPC1).
FT                                {ECO:0000269|PubMed:11754101}.
FT                                /FTId=VAR_043259.
FT   VARIANT     950    950       V -> M (in NPC1; adult form;
FT                                dbSNP:rs120074135).
FT                                {ECO:0000269|PubMed:11333381,
FT                                ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_015563.
FT   VARIANT     954    954       S -> L (in NPC1; dbSNP:rs543206298).
FT                                {ECO:0000269|PubMed:10521290,
FT                                ECO:0000269|PubMed:11182931,
FT                                ECO:0000269|PubMed:11754101}.
FT                                /FTId=VAR_008831.
FT   VARIANT     956    956       C -> Y (in NPC1; late infantile form).
FT                                {ECO:0000269|PubMed:11182931}.
FT                                /FTId=VAR_008832.
FT   VARIANT     958    958       R -> L (in NPC1).
FT                                {ECO:0000269|PubMed:11754101}.
FT                                /FTId=VAR_043260.
FT   VARIANT     958    958       R -> Q (in NPC1; dbSNP:rs120074132).
FT                                {ECO:0000269|PubMed:11349231}.
FT                                /FTId=VAR_015564.
FT   VARIANT     959    959       V -> E (in NPC1).
FT                                {ECO:0000269|PubMed:16098014}.
FT                                /FTId=VAR_043261.
FT   VARIANT     961    966       NITDQF -> S (in NPC1).
FT                                {ECO:0000269|PubMed:16098014}.
FT                                /FTId=VAR_043262.
FT   VARIANT     961    961       N -> S (in NPC1; dbSNP:rs34084984).
FT                                {ECO:0000269|PubMed:16802107}.
FT                                /FTId=VAR_043263.
FT   VARIANT     968    968       N -> S (in NPC1; dbSNP:rs773767253).
FT                                {ECO:0000269|PubMed:15774455,
FT                                ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_043264.
FT   VARIANT     971    971       V -> G. {ECO:0000269|PubMed:11754101}.
FT                                /FTId=VAR_043265.
FT   VARIANT     976    976       C -> R (in NPC1).
FT                                {ECO:0000269|PubMed:11349231}.
FT                                /FTId=VAR_043266.
FT   VARIANT     978    978       R -> C (in NPC1; dbSNP:rs28942108).
FT                                {ECO:0000269|PubMed:11349231,
FT                                ECO:0000269|PubMed:11479732}.
FT                                /FTId=VAR_015565.
FT   VARIANT     986    986       G -> S (in NPC1).
FT                                {ECO:0000269|PubMed:11333381}.
FT                                /FTId=VAR_043267.
FT   VARIANT     992    992       G -> A (in NPC1; dbSNP:rs757534240).
FT                                {ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_043268.
FT   VARIANT     992    992       G -> R (in NPC1; dbSNP:rs80358254).
FT                                {ECO:0000269|PubMed:11333381,
FT                                ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_015566.
FT   VARIANT     992    992       G -> W (in NPC1; found in the Nova
FT                                Scotian clinical variant;
FT                                dbSNP:rs80358254).
FT                                {ECO:0000269|PubMed:10521290,
FT                                ECO:0000269|PubMed:11545687,
FT                                ECO:0000269|PubMed:12401890,
FT                                ECO:0000269|PubMed:16126423,
FT                                ECO:0000269|PubMed:9634529}.
FT                                /FTId=VAR_008833.
FT   VARIANT     996    996       M -> R (in NPC1).
FT                                {ECO:0000269|PubMed:11182931}.
FT                                /FTId=VAR_043269.
FT   VARIANT    1004   1004       S -> L (in NPC1; dbSNP:rs150334966).
FT                                {ECO:0000269|PubMed:11349231}.
FT                                /FTId=VAR_043270.
FT   VARIANT    1007   1007       P -> A (in NPC1; dbSNP:rs80358257).
FT                                {ECO:0000269|PubMed:10521290,
FT                                ECO:0000269|PubMed:11333381,
FT                                ECO:0000269|PubMed:11349231,
FT                                ECO:0000269|PubMed:11754101,
FT                                ECO:0000269|PubMed:12401890,
FT                                ECO:0000269|PubMed:16098014,
FT                                ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_008834.
FT   VARIANT    1012   1012       G -> D (in NPC1).
FT                                {ECO:0000269|PubMed:11545687}.
FT                                /FTId=VAR_043271.
FT   VARIANT    1015   1015       G -> V (in NPC1; dbSNP:rs761773567).
FT                                {ECO:0000269|PubMed:15774455}.
FT                                /FTId=VAR_043272.
FT   VARIANT    1016   1016       H -> R (in NPC1; dbSNP:rs140211089).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043273.
FT   VARIANT    1023   1023       V -> G (in NPC1).
FT                                {ECO:0000269|PubMed:11349231}.
FT                                /FTId=VAR_043274.
FT   VARIANT    1034   1034       G -> R (in NPC1).
FT                                {ECO:0000269|PubMed:15774455}.
FT                                /FTId=VAR_043275.
FT   VARIANT    1035   1035       A -> V (in NPC1; dbSNP:rs28942107).
FT                                {ECO:0000269|PubMed:11479732,
FT                                ECO:0000269|PubMed:16098014}.
FT                                /FTId=VAR_015567.
FT   VARIANT    1036   1036       T -> K (in NPC1).
FT                                {ECO:0000269|PubMed:16098014}.
FT                                /FTId=VAR_043276.
FT   VARIANT    1036   1036       T -> M (in NPC1; dbSNP:rs28942104).
FT                                {ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_008835.
FT   VARIANT    1049   1049       A -> V. {ECO:0000269|PubMed:11754101}.
FT                                /FTId=VAR_043277.
FT   VARIANT    1054   1054       A -> T (in NPC1; dbSNP:rs80358258).
FT                                {ECO:0000269|PubMed:11333381}.
FT                                /FTId=VAR_043278.
FT   VARIANT    1059   1059       R -> Q (in NPC1; dbSNP:rs771000314).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043279.
FT   VARIANT    1061   1061       I -> T (in NPC1; late infantile form;
FT                                dbSNP:rs80358259).
FT                                {ECO:0000269|PubMed:10521290,
FT                                ECO:0000269|PubMed:10521297,
FT                                ECO:0000269|PubMed:11182931,
FT                                ECO:0000269|PubMed:11333381,
FT                                ECO:0000269|PubMed:11349231,
FT                                ECO:0000269|PubMed:11479732,
FT                                ECO:0000269|PubMed:11754101,
FT                                ECO:0000269|PubMed:12401890,
FT                                ECO:0000269|PubMed:16098014,
FT                                ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_008836.
FT   VARIANT    1062   1062       A -> V (in NPC1).
FT                                {ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_043280.
FT   VARIANT    1066   1066       T -> N (in NPC1; dbSNP:rs772622214).
FT                                {ECO:0000269|PubMed:16098014}.
FT                                /FTId=VAR_043281.
FT   VARIANT    1087   1087       F -> L (in NPC1; dbSNP:rs746715353).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043282.
FT   VARIANT    1088   1088       Y -> C (in NPC1; juvenile form;
FT                                dbSNP:rs28942106).
FT                                {ECO:0000269|PubMed:11182931}.
FT                                /FTId=VAR_008837.
FT   VARIANT    1089   1089       E -> K (in NPC1; dbSNP:rs374526072).
FT                                {ECO:0000269|PubMed:11349231}.
FT                                /FTId=VAR_043283.
FT   VARIANT    1094   1094       I -> T (in NPC1).
FT                                {ECO:0000269|PubMed:12408188}.
FT                                /FTId=VAR_043284.
FT   VARIANT    1097   1097       D -> N (in NPC1; dbSNP:rs758829443).
FT                                {ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_043285.
FT   VARIANT    1137   1137       N -> I (in NPC1).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043286.
FT   VARIANT    1140   1140       G -> V (in NPC1).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043287.
FT   VARIANT    1142   1142       M -> T (in NPC1; dbSNP:rs778878523).
FT                                {ECO:0000269|PubMed:11333381,
FT                                ECO:0000269|PubMed:11349231}.
FT                                /FTId=VAR_043288.
FT   VARIANT    1150   1150       N -> K (in NPC1).
FT                                {ECO:0000269|PubMed:11349231}.
FT                                /FTId=VAR_043289.
FT   VARIANT    1156   1156       N -> I (in NPC1; dbSNP:rs28942105).
FT                                {ECO:0000269|PubMed:16098014}.
FT                                /FTId=VAR_043290.
FT   VARIANT    1156   1156       N -> S (in NPC1; dbSNP:rs28942105).
FT                                {ECO:0000269|PubMed:11349231,
FT                                ECO:0000269|PubMed:11545687,
FT                                ECO:0000269|PubMed:12401890,
FT                                ECO:0000269|PubMed:16098014}.
FT                                /FTId=VAR_008838.
FT   VARIANT    1165   1165       V -> M (in NPC1; dbSNP:rs748862167).
FT                                {ECO:0000269|PubMed:11349231}.
FT                                /FTId=VAR_043291.
FT   VARIANT    1167   1167       F -> L (in NPC1).
FT                                /FTId=VAR_008839.
FT   VARIANT    1168   1168       C -> Y (in NPC1).
FT                                {ECO:0000269|PubMed:11333381}.
FT                                /FTId=VAR_043292.
FT   VARIANT    1174   1174       A -> V (in NPC1; dbSNP:rs780175800).
FT                                {ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_043293.
FT   VARIANT    1186   1186       R -> H (in NPC1; dbSNP:rs200444084).
FT                                {ECO:0000269|PubMed:11333381,
FT                                ECO:0000269|PubMed:11349231,
FT                                ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_008840.
FT   VARIANT    1189   1189       E -> G (in NPC1; dbSNP:rs369098773).
FT                                {ECO:0000269|PubMed:11349231}.
FT                                /FTId=VAR_043294.
FT   VARIANT    1205   1205       T -> K (in NPC1; dbSNP:rs758902805).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043295.
FT   VARIANT    1205   1205       T -> R (in NPC1).
FT                                {ECO:0000269|PubMed:11182931}.
FT                                /FTId=VAR_043296.
FT   VARIANT    1212   1212       V -> L (in NPC1; dbSNP:rs753419933).
FT                                {ECO:0000269|PubMed:15774455}.
FT                                /FTId=VAR_043297.
FT   VARIANT    1213   1213       L -> F (in NPC1; juvenile form;
FT                                dbSNP:rs120074131).
FT                                {ECO:0000269|PubMed:11182931}.
FT                                /FTId=VAR_008841.
FT   VARIANT    1213   1213       L -> V (in NPC1; dbSNP:rs766178353).
FT                                {ECO:0000269|PubMed:10521290}.
FT                                /FTId=VAR_008842.
FT   VARIANT    1216   1216       A -> V (in NPC1).
FT                                {ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_043298.
FT   VARIANT    1220   1220       I -> T.
FT                                /FTId=VAR_008843.
FT   VARIANT    1224   1224       F -> L (in NPC1).
FT                                {ECO:0000269|PubMed:16098014}.
FT                                /FTId=VAR_043299.
FT   VARIANT    1236   1236       G -> E (in NPC1; dbSNP:rs761653115).
FT                                {ECO:0000269|PubMed:11182931}.
FT                                /FTId=VAR_043300.
FT   VARIANT    1240   1240       G -> R (in NPC1; dbSNP:rs745892286).
FT                                {ECO:0000269|PubMed:16126423}.
FT                                /FTId=VAR_043301.
FT   VARIANT    1249   1249       S -> G (in NPC1).
FT                                {ECO:0000269|PubMed:12955717}.
FT                                /FTId=VAR_043302.
FT   VARIANT    1266   1266       R -> Q (common polymorphism in Japanese;
FT                                dbSNP:rs1805084).
FT                                {ECO:0000269|PubMed:10480349,
FT                                ECO:0000269|PubMed:12955717,
FT                                ECO:0000269|PubMed:15774455,
FT                                ECO:0000269|PubMed:16098014}.
FT                                /FTId=VAR_008844.
FT   MUTAGEN      26     27       VW->AA: Nearly abolishes 25-
FT                                hydroxycholesterol binding. Reduces
FT                                cholesterol binding.
FT                                {ECO:0000269|PubMed:19563754}.
FT   MUTAGEN      39     41       RYN->AAA: Strongly reduces cholesterol
FT                                and 25-hydroxycholesterol binding.
FT                                {ECO:0000269|PubMed:19563754}.
FT   MUTAGEN      41     41       N->A: Nearly abolishes cholesterol and
FT                                25-hydroxycholesterol binding.
FT                                {ECO:0000269|PubMed:19563754}.
FT   MUTAGEN      63     63       C->S: Loss of function.
FT                                {ECO:0000269|PubMed:9927649}.
FT   MUTAGEN      70     70       N->Q: Reduces glycosylation; when
FT                                associated with Q-122 and Q-185. No
FT                                effect on cholesterol and 25-
FT                                hydroxycholesterol binding.
FT                                {ECO:0000269|PubMed:19563754}.
FT   MUTAGEN      82     83       TL->AA: Strongly reduces cholesterol and
FT                                25-hydroxycholesterol binding.
FT                                {ECO:0000269|PubMed:19563754}.
FT   MUTAGEN      97     97       C->S: Loss of function.
FT                                {ECO:0000269|PubMed:9927649}.
FT   MUTAGEN     101    102       FY->AA: Strongly reduces 25-
FT                                hydroxycholesterol binding. No effect on
FT                                cholesterol binding.
FT                                {ECO:0000269|PubMed:19563754}.
FT   MUTAGEN     106    108       NLF->AAA: Nearly abolishes cholesterol
FT                                and 25-hydroxycholesterol binding.
FT                                {ECO:0000269|PubMed:19563754}.
FT   MUTAGEN     110    112       ELT->AAA: No effect on cholesterol and
FT                                25-hydroxycholesterol binding and
FT                                transfer. {ECO:0000269|PubMed:19563754}.
FT   MUTAGEN     122    122       N->Q: Reduces glycosylation; when
FT                                associated with Q-70 and Q-185. No effect
FT                                on cholesterol and 25-hydroxycholesterol
FT                                binding. {ECO:0000269|PubMed:19563754}.
FT   MUTAGEN     144    145       LQ->AA: Strongly reduces 25-
FT                                hydroxycholesterol binding. No effect on
FT                                cholesterol binding.
FT                                {ECO:0000269|PubMed:19563754}.
FT   MUTAGEN     146    147       YY->AA: Strongly reduces 25-
FT                                hydroxycholesterol binding. No effect on
FT                                cholesterol binding.
FT                                {ECO:0000269|PubMed:19563754}.
FT   MUTAGEN     175    176       LL->AA: No effect on cholesterol or 25-
FT                                hydroxycholesterol binding. Strongly
FT                                reduces cholesterol transfer to liposomes
FT                                in a NPC2-dependent manner.
FT                                {ECO:0000269|PubMed:19563754}.
FT   MUTAGEN     180    182       DAD->AAA: Strongly reduces cholesterol
FT                                transfer to liposomes in a NPC2-dependent
FT                                manner. {ECO:0000269|PubMed:19563754}.
FT   MUTAGEN     185    185       N->Q: Reduces glycosylation; when
FT                                associated with Q-70 and Q-122. No effect
FT                                on cholesterol and 25-hydroxycholesterol
FT                                binding. Strongly reduces cholesterol
FT                                transfer to liposomes in a NPC2-dependent
FT                                manner. {ECO:0000269|PubMed:19563754}.
FT   MUTAGEN     187    188       TN->AA: Strongly reduces 25-
FT                                hydroxycholesterol binding and
FT                                cholesterol transfer to liposomes in a
FT                                NPC2-dependent manner.
FT                                {ECO:0000269|PubMed:19563754}.
FT   MUTAGEN     191    192       EY->AA: No effect on cholesterol or 25-
FT                                hydroxycholesterol binding. Nearly
FT                                abolishes cholesterol transfer to
FT                                liposomes in a NPC2-dependent manner.
FT                                {ECO:0000269|PubMed:19563754}.
FT   MUTAGEN     195    196       NK->AA: Strongly reduces 25-
FT                                hydroxycholesterol binding. No effect on
FT                                cholesterol binding.
FT                                {ECO:0000269|PubMed:19563754}.
FT   MUTAGEN     197    198       DN->AA: Strongly reduces cholesterol and
FT                                25-hydroxycholesterol binding.
FT                                {ECO:0000269|PubMed:19563754}.
FT   MUTAGEN     199    200       GQ->AA: Strongly reduces 25-
FT                                hydroxycholesterol binding and
FT                                cholesterol transfer to liposomes in a
FT                                NPC2-dependent manner.
FT                                {ECO:0000269|PubMed:19563754}.
FT   MUTAGEN     202    203       PF->AA: Abolishes cholesterol and 25-
FT                                hydroxycholesterol binding.
FT                                {ECO:0000269|PubMed:19563754}.
FT   MUTAGEN     204    205       TI->AA: Strongly reduces cholesterol and
FT                                25-hydroxycholesterol binding.
FT                                {ECO:0000269|PubMed:19563754}.
FT   MUTAGEN     660    660       G->R: Loss of function.
FT                                {ECO:0000269|PubMed:19563754}.
FT   STRAND       26     35       {ECO:0000244|PDB:3GKJ}.
FT   STRAND       38     43       {ECO:0000244|PDB:3GKJ}.
FT   HELIX        53     55       {ECO:0000244|PDB:3GKJ}.
FT   HELIX        56     62       {ECO:0000244|PDB:3GKJ}.
FT   HELIX        64     66       {ECO:0000244|PDB:3GKJ}.
FT   STRAND       72     74       {ECO:0000244|PDB:3GKJ}.
FT   HELIX        77     85       {ECO:0000244|PDB:3GKJ}.
FT   HELIX        88     94       {ECO:0000244|PDB:3GKJ}.
FT   HELIX        98    113       {ECO:0000244|PDB:3GKJ}.
FT   HELIX       117    120       {ECO:0000244|PDB:3GKJ}.
FT   STRAND      121    130       {ECO:0000244|PDB:3GKJ}.
FT   TURN        132    134       {ECO:0000244|PDB:3GKJ}.
FT   STRAND      137    148       {ECO:0000244|PDB:3GKJ}.
FT   HELIX       150    160       {ECO:0000244|PDB:3GKJ}.
FT   STRAND      168    171       {ECO:0000244|PDB:3GKJ}.
FT   HELIX       173    176       {ECO:0000244|PDB:3GKJ}.
FT   STRAND      177    179       {ECO:0000244|PDB:3GKJ}.
FT   TURN        181    183       {ECO:0000244|PDB:3GKJ}.
FT   HELIX       186    193       {ECO:0000244|PDB:3GKJ}.
FT   HELIX       196    198       {ECO:0000244|PDB:3GKJ}.
FT   STRAND      199    209       {ECO:0000244|PDB:3GKJ}.
FT   HELIX       240    242       {ECO:0000244|PDB:3GKJ}.
FT   HELIX       244    246       {ECO:0000244|PDB:3GKJ}.
FT   HELIX       350    365       {ECO:0000244|PDB:5I31}.
FT   STRAND      367    371       {ECO:0000244|PDB:5I31}.
FT   HELIX       380    382       {ECO:0000244|PDB:5KWY}.
FT   HELIX       385    398       {ECO:0000244|PDB:5F18}.
FT   TURN        399    402       {ECO:0000244|PDB:5F18}.
FT   STRAND      403    411       {ECO:0000244|PDB:5F18}.
FT   STRAND      418    420       {ECO:0000244|PDB:5F18}.
FT   STRAND      423    425       {ECO:0000244|PDB:5HNS}.
FT   STRAND      429    431       {ECO:0000244|PDB:5F18}.
FT   HELIX       433    435       {ECO:0000244|PDB:5F18}.
FT   HELIX       437    451       {ECO:0000244|PDB:5F18}.
FT   STRAND      454    457       {ECO:0000244|PDB:5F18}.
FT   STRAND      460    463       {ECO:0000244|PDB:5F18}.
FT   HELIX       464    467       {ECO:0000244|PDB:5F18}.
FT   TURN        471    475       {ECO:0000244|PDB:5F18}.
FT   HELIX       484    488       {ECO:0000244|PDB:5F18}.
FT   HELIX       492    495       {ECO:0000244|PDB:5F18}.
FT   STRAND      505    507       {ECO:0000244|PDB:5F18}.
FT   HELIX       509    516       {ECO:0000244|PDB:5F18}.
FT   TURN        526    530       {ECO:0000244|PDB:5F18}.
FT   STRAND      536    538       {ECO:0000244|PDB:5F18}.
FT   HELIX       543    546       {ECO:0000244|PDB:5F18}.
FT   STRAND      547    549       {ECO:0000244|PDB:5F18}.
FT   HELIX       555    557       {ECO:0000244|PDB:5F18}.
FT   STRAND      559    568       {ECO:0000244|PDB:5F18}.
FT   HELIX       574    592       {ECO:0000244|PDB:5F18}.
FT   STRAND      600    603       {ECO:0000244|PDB:5F18}.
FT   HELIX       608    611       {ECO:0000244|PDB:5KWY}.
FT   HELIX       621    638       {ECO:0000244|PDB:5I31}.
FT   HELIX       660    671       {ECO:0000244|PDB:5I31}.
FT   STRAND      672    674       {ECO:0000244|PDB:5I31}.
FT   HELIX       677    679       {ECO:0000244|PDB:5I31}.
FT   STRAND      680    682       {ECO:0000244|PDB:5I31}.
FT   HELIX       685    687       {ECO:0000244|PDB:5I31}.
FT   HELIX       690    707       {ECO:0000244|PDB:5I31}.
FT   TURN        728    730       {ECO:0000244|PDB:5I31}.
FT   HELIX       731    746       {ECO:0000244|PDB:5I31}.
FT   HELIX       755    775       {ECO:0000244|PDB:5I31}.
FT   TURN        776    778       {ECO:0000244|PDB:5I31}.
FT   HELIX       779    789       {ECO:0000244|PDB:5I31}.
FT   HELIX       834    851       {ECO:0000244|PDB:5I31}.
FT   HELIX       866    874       {ECO:0000244|PDB:5I31}.
FT   HELIX       906    911       {ECO:0000244|PDB:5I31}.
FT   HELIX       912    915       {ECO:0000244|PDB:5I31}.
FT   STRAND      916    918       {ECO:0000244|PDB:5I31}.
FT   HELIX       928    932       {ECO:0000244|PDB:5I31}.
FT   HELIX       940    943       {ECO:0000244|PDB:5I31}.
FT   TURN        954    957       {ECO:0000244|PDB:5I31}.
FT   STRAND      959    961       {ECO:0000244|PDB:5I31}.
FT   HELIX      1038   1051       {ECO:0000244|PDB:5I31}.
FT   TURN       1052   1054       {ECO:0000244|PDB:5I31}.
FT   HELIX      1084   1088       {ECO:0000244|PDB:5I31}.
FT   HELIX      1094   1115       {ECO:0000244|PDB:5I31}.
FT   HELIX      1125   1137       {ECO:0000244|PDB:5I31}.
FT   TURN       1138   1140       {ECO:0000244|PDB:5I31}.
FT   HELIX      1147   1152       {ECO:0000244|PDB:5I31}.
FT   HELIX      1155   1157       {ECO:0000244|PDB:5I31}.
FT   HELIX      1158   1170       {ECO:0000244|PDB:5I31}.
FT   TURN       1186   1190       {ECO:0000244|PDB:5I31}.
FT   HELIX      1191   1200       {ECO:0000244|PDB:5I31}.
FT   STRAND     1203   1205       {ECO:0000244|PDB:5I31}.
FT   TURN       1217   1220       {ECO:0000244|PDB:5I31}.
FT   HELIX      1222   1235       {ECO:0000244|PDB:5I31}.
FT   HELIX      1238   1242       {ECO:0000244|PDB:5I31}.
FT   TURN       1243   1245       {ECO:0000244|PDB:5I31}.
SQ   SEQUENCE   1278 AA;  142167 MW;  DA1523E09822E5C7 CRC64;
     MTARGLALGL LLLLLCPAQV FSQSCVWYGE CGIAYGDKRY NCEYSGPPKP LPKDGYDLVQ
     ELCPGFFFGN VSLCCDVRQL QTLKDNLQLP LQFLSRCPSC FYNLLNLFCE LTCSPRQSQF
     LNVTATEDYV DPVTNQTKTN VKELQYYVGQ SFANAMYNAC RDVEAPSSND KALGLLCGKD
     ADACNATNWI EYMFNKDNGQ APFTITPVFS DFPVHGMEPM NNATKGCDES VDEVTAPCSC
     QDCSIVCGPK PQPPPPPAPW TILGLDAMYV IMWITYMAFL LVFFGAFFAV WCYRKRYFVS
     EYTPIDSNIA FSVNASDKGE ASCCDPVSAA FEGCLRRLFT RWGSFCVRNP GCVIFFSLVF
     ITACSSGLVF VRVTTNPVDL WSAPSSQARL EKEYFDQHFG PFFRTEQLII RAPLTDKHIY
     QPYPSGADVP FGPPLDIQIL HQVLDLQIAI ENITASYDNE TVTLQDICLA PLSPYNTNCT
     ILSVLNYFQN SHSVLDHKKG DDFFVYADYH THFLYCVRAP ASLNDTSLLH DPCLGTFGGP
     VFPWLVLGGY DDQNYNNATA LVITFPVNNY YNDTEKLQRA QAWEKEFINF VKNYKNPNLT
     ISFTAERSIE DELNRESDSD VFTVVISYAI MFLYISLALG HMKSCRRLLV DSKVSLGIAG
     ILIVLSSVAC SLGVFSYIGL PLTLIVIEVI PFLVLAVGVD NIFILVQAYQ RDERLQGETL
     DQQLGRVLGE VAPSMFLSSF SETVAFFLGA LSVMPAVHTF SLFAGLAVFI DFLLQITCFV
     SLLGLDIKRQ EKNRLDIFCC VRGAEDGTSV QASESCLFRF FKNSYSPLLL KDWMRPIVIA
     IFVGVLSFSI AVLNKVDIGL DQSLSMPDDS YMVDYFKSIS QYLHAGPPVY FVLEEGHDYT
     SSKGQNMVCG GMGCNNDSLV QQIFNAAQLD NYTRIGFAPS SWIDDYFDWV KPQSSCCRVD
     NITDQFCNAS VVDPACVRCR PLTPEGKQRP QGGDFMRFLP MFLSDNPNPK CGKGGHAAYS
     SAVNILLGHG TRVGATYFMT YHTVLQTSAD FIDALKKARL IASNVTETMG INGSAYRVFP
     YSVFYVFYEQ YLTIIDDTIF NLGVSLGAIF LVTMVLLGCE LWSAVIMCAT IAMVLVNMFG
     VMWLWGISLN AVSLVNLVMS CGISVEFCSH ITRAFTVSMK GSRVERAEEA LAHMGSSVFS
     GITLTKFGGI VVLAFAKSQI FQIFYFRMYL AMVLLGATHG LIFLPVLLSY IGPSVNKAKS
     CATEERYKGT ERERLLNF
//
